{"id":"https://openalex.org/W1994587232","doi":"https://doi.org/10.1592/phco.26.4.461","title":"Evaluation of Treatment with Direct Thrombin Inhibitors in Patients with Heparin\u2010Induced Thrombocytopenia","display_name":"Evaluation of Treatment with Direct Thrombin Inhibitors in Patients with Heparin\u2010Induced Thrombocytopenia","alternate_titles":[],"publication_year":2006,"publication_date":"2006-03-22","ids":{"openalex":"https://openalex.org/W1994587232","doi":"https://doi.org/10.1592/phco.26.4.461","mag":"1994587232","pmid":"https://pubmed.ncbi.nlm.nih.gov/16553503"},"language":"en","primary_location":{"id":"doi:10.1592/phco.26.4.461","doi":"https://doi.org/10.1592/phco.26.4.461","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.26.4.461","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994587232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070501184","display_name":"Cathyyen H. Dang","orcid":"https://orcid.org/0000-0003-4307-6294","observed_orcids":["https://orcid.org/0000-0003-4307-6294"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cathyyen H. Dang","raw_affiliation_strings":["Department of Pharmacy and Clinical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina 29425, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Clinical Sciences, South Carolina College of Pharmacy, Medical University of South Carolina, Charleston, South Carolina 29425, USA","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088749034","display_name":"Valerie Durkalski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valerie L. Durkalski","raw_affiliation_strings":["Department of Biostatistics, Bioinformatics, and Epidemiology, College of Medicine Medical University of South Carolina, Charleston, South Carolina","Department of Biostatistics, Bioinformatics & Epidemiology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Bioinformatics, and Epidemiology, College of Medicine Medical University of South Carolina, Charleston, South Carolina","institution_ids":["https://openalex.org/I153297377"]},{"raw_affiliation_string":"Department of Biostatistics, Bioinformatics & Epidemiology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011806150","display_name":"Jean M. Nappi","orcid":"https://orcid.org/0000-0001-8667-1515","observed_orcids":["https://orcid.org/0000-0001-8667-1515"]},"institutions":[{"id":"https://openalex.org/I155781252","display_name":"University of South Carolina","ror":"https://ror.org/02b6qw903","country_code":"US","type":"education","lineage":["https://openalex.org/I155781252"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jean M. Nappi","raw_affiliation_strings":["Department of Pharmacy and Clinical Sciences, South Carolina College of Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy and Clinical Sciences, South Carolina College of Pharmacy","institution_ids":["https://openalex.org/I155781252"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011806150"],"corresponding_institution_ids":["https://openalex.org/I155781252"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":5.1267,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.95716411,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"26","issue":"4","first_page":"461","last_page":"468"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heparin-induced-thrombocytopenia","display_name":"heparin-induced thrombocytopenia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/direct-thrombin-inhibitors","display_name":"direct thrombin inhibitors","score":0.9750000238418579},{"id":"https://openalex.org/keywords/bivalirudin","display_name":"bivalirudin","score":0.949999988079071},{"id":"https://openalex.org/keywords/argatroban","display_name":"argatroban","score":0.9950000047683716},{"id":"https://openalex.org/keywords/lepirudin","display_name":"lepirudin","score":1.0},{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/activated-partial-thromboplastin-time","display_name":"activated partial thromboplastin time","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bleeding-complications","display_name":"bleeding complications","score":0.4860000014305115},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.6029999852180481},{"id":"https://openalex.org/keywords/deep-vein-thrombosis","display_name":"deep vein thrombosis","score":0.902999997138977},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.4909999966621399},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.4909999966621399},{"id":"https://openalex.org/keywords/drug-costs","display_name":"drug costs","score":0.3400000035762787},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.30799999833106995}],"concepts":[{"id":"https://openalex.org/C2776472838","wikidata":"https://www.wikidata.org/wiki/Q1598365","display_name":"Heparin-induced thrombocytopenia","level":3,"score":0.7637298107147217},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.722661018371582},{"id":"https://openalex.org/C57002609","wikidata":"https://www.wikidata.org/wiki/Q5281999","display_name":"Discovery and development of direct thrombin inhibitors","level":4,"score":0.715893030166626},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.5705474615097046},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4572964608669281},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4142364263534546},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.35179221630096436},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28739404678344727}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001120","descriptor_name":"Arginine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006629","descriptor_name":"Hirudins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010314","descriptor_name":"Partial Thromboplastin Time","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010875","descriptor_name":"Pipecolic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1592/phco.26.4.461","doi":"https://doi.org/10.1592/phco.26.4.461","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.26.4.461","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:16553503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16553503","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W631714011","https://openalex.org/W1892579436","https://openalex.org/W1976017990","https://openalex.org/W2070063154","https://openalex.org/W2070676143","https://openalex.org/W2072783106","https://openalex.org/W2083664576","https://openalex.org/W2120423596","https://openalex.org/W2150983644","https://openalex.org/W2171469067","https://openalex.org/W2316460201","https://openalex.org/W2417214686"],"related_works":["https://openalex.org/W1969719994","https://openalex.org/W2109814761","https://openalex.org/W2981434036","https://openalex.org/W6906077126","https://openalex.org/W2304938645","https://openalex.org/W2623770535","https://openalex.org/W2343646042","https://openalex.org/W1991726020","https://openalex.org/W2582558926","https://openalex.org/W2153622822"],"abstract_inverted_index":{"STUDY":[0],"OBJECTIVE:":[1],"To":[2],"evaluate":[3],"the":[4,71,75,87,93,105,110,156,162,176,180,207,216,240,272,281],"efficacy,":[5],"safety,":[6],"and":[7,15,45,49,101,119,143,165,209,234,262,285],"associated":[8],"costs":[9,186],"of":[10,89,150,221,290],"anticoagulation":[11,301],"with":[12,20,53,195,198,253],"argatroban,":[13,55,118],"bivalirudin,":[14,54,115],"lepirudin":[16,57,139,166,177,217],"for":[17,58,78,251,288,300],"managing":[18],"patients":[19,38,107,252],"heparin-induced":[21],"thrombocytopenia":[22],"(HIT)":[23],"or":[24,56,138,200,255],"presumed":[25,256],"HIT.":[26,257],"DESIGN:":[27],"Retrospective":[28],"medical":[29],"record":[30],"review.":[31],"SETTING:":[32],"University-affiliated":[33],"teaching":[34],"hospital.":[35],"PATIENTS:":[36],"Forty-two":[37],"who":[39,50,108,126],"were":[40,51,86,187,204,237,247],"hospitalized":[41],"between":[42],"January":[43],"1":[44],"December":[46],"31,":[47],"2004,":[48],"treated":[52],"at":[59],"least":[60],"24":[61,113,144],"hours.":[62],"MEASUREMENTS":[63],"AND":[64],"MAIN":[65],"RESULTS:":[66],"The":[67],"primary":[68],"outcome":[69],"was":[70,153,173,193],"time":[72,82],"to":[73,294],"reach":[74],"desired":[76],"goal":[77],"activated":[79],"partial":[80],"thromboplastin":[81],"(aPTT).":[83],"Secondary":[84],"outcomes":[85,223],"number":[88],"aPTT":[90],"measurements":[91],"within":[92],"therapeutic":[94,128,151],"range,":[95],"costs,":[96],"treatment":[97,298],"duration,":[98],"clinical":[99,222],"outcomes,":[100],"adverse":[102],"events.":[103],"Of":[104],"42":[106],"met":[109],"inclusion":[111],"criteria,":[112],"received":[114,117,121],"13":[116],"5":[120],"lepirudin.":[122,201],"Patients":[123],"receiving":[124,135],"bivalirudin":[125,163,199,210,266,292],"reached":[127],"aPTTs":[129],"attained":[130],"them":[131],"sooner":[132],"than":[133,179,197,214,271],"those":[134],"either":[136],"argatroban":[137,157,196,208],"(8.5":[140],"vs":[141],"14":[142],"hrs,":[145],"respectively,":[146],"p=0.124).":[147],"Average":[148,170],"percentage":[149],"aPTTs/patient":[152],"greatest":[154],"in":[155,175,206,215],"group":[158,178],"(62%),":[159],"followed":[160],"by":[161,280],"(57%)":[164],"(29%)":[167],"groups":[168],"(p=0.062).":[169],"drug":[171],"cost/day/patient":[172],"greater":[174],"other":[181,273],"groups,":[182,211],"whereas":[183],"average":[184,260,263],"laboratory":[185],"similar":[188,205,238],"among":[189,239],"groups.":[190,242],"Treatment":[191],"duration":[192],"longer":[194],"Bleeding":[202],"rates":[203],"but":[212],"higher":[213],"group.":[218],"A":[219],"composite":[220],"(deep":[224],"vein":[225],"thrombosis,":[226],"nonfatal":[227,230],"myocardial":[228],"infarction,":[229],"stroke,":[231],"limb":[232],"amputation,":[233],"all-cause":[235],"mortality)":[236],"three":[241,245],"CONCLUSION:":[243],"All":[244],"drugs":[246],"effective":[248],"as":[249],"anticoagulants":[250],"HIT":[254],"Based":[258],"on":[259],"use":[261],"wholesale":[264],"price,":[265],"cost":[267],"less":[268],"per":[269],"day":[270],"two":[274],"agents.":[275],"Although":[276],"not":[277],"yet":[278],"approved":[279],"United":[282],"States":[283],"Food":[284],"Drug":[286],"Administration":[287],"management":[289],"HIT,":[291],"appears":[293],"be":[295],"a":[296],"viable":[297],"alternative":[299],"therapy.":[302]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994587232","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
